Patent intelligence · US
US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
Patent details — US 12419873
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 23, 2025
- Expiration
- Sep 18, 2045
- Applicant
- ZHUHAI UNITED LABORATORIES CO., LTD.
- Claims
- 16
- CPC classes
- A61K, A61K31/437, A61K31/438, A61P
Quick answer
US 12419873 (Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases) is held by ZHUHAI UNITED LABORATORIES CO., LTD.. Status: granted. Granted Sep 23, 2025. Expires Sep 18, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ZHUHAI UNITED LABORATORIES CO., LTD.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K31/437, A61K31/438, A61P, A61P1/04, A61P17/00
More from ZHUHAI UNITED LABORATORIES CO., LTD.
Related pharmaceutical patents in our USPTO index.
-
US 12419941
Poultry drinking water-based vaccine delivery system and method
granted -
US 12415845
Methods of producing T cell populations using hydroxycitric acid and/or a salt thereof
granted -
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12410259
CD47 targeted therapies for the treatment of infectious disease
granted -
US 12404317
T cell receptors recognizing MHC class II-restricted MAGE-A3
granted -
US 12397066
Delivery of gene therapy treatments
granted -
US 12398123
Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria
granted
Frequently asked questions
What is US patent 12419873?
US 12419873 (Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases) is held by ZHUHAI UNITED LABORATORIES CO., LTD.. Status: granted. Granted Sep 23, 2025. Expires Sep 18, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12419873?
ZHUHAI UNITED LABORATORIES CO., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3,720 pharmaceutical patents for this assignee.
When does US 12419873 expire?
Our index shows an expiration date of Sep 18, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.